MaxCyte to Present on Development of Novel Tumor-Targeted Enhanced Potency T Cell Immunotherapy at The 15th Annual Meeting of th

MaxCyte will be presenting results on the development of an engineered tumor-targeted T cell therapy uniquely enabled by the use... [more]

View complete Press Release article